UA74991C2 - Oral therapeutic composition with controlled release of dihydrocodeine - Google Patents

Oral therapeutic composition with controlled release of dihydrocodeine Download PDF

Info

Publication number
UA74991C2
UA74991C2 UA20041109250A UA20041109250A UA74991C2 UA 74991 C2 UA74991 C2 UA 74991C2 UA 20041109250 A UA20041109250 A UA 20041109250A UA 20041109250 A UA20041109250 A UA 20041109250A UA 74991 C2 UA74991 C2 UA 74991C2
Authority
UA
Ukraine
Prior art keywords
weight
active substance
mixture
composition according
dihydrocodeine
Prior art date
Application number
UA20041109250A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva As filed Critical Zentiva As
Publication of UA74991C2 publication Critical patent/UA74991C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
UA20041109250A 2002-04-12 2003-10-04 Oral therapeutic composition with controlled release of dihydrocodeine UA74991C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SK501-2002A SK286107B6 (sk) 2002-04-12 2002-04-12 Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy
PCT/SK2003/000008 WO2003086365A1 (en) 2002-04-12 2003-04-10 Analgesical oral composition with controlled release of an opioid

Publications (1)

Publication Number Publication Date
UA74991C2 true UA74991C2 (en) 2006-02-15

Family

ID=29247067

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20041109250A UA74991C2 (en) 2002-04-12 2003-10-04 Oral therapeutic composition with controlled release of dihydrocodeine

Country Status (13)

Country Link
EP (1) EP1494656B1 (pl)
AT (1) ATE398446T1 (pl)
AU (1) AU2003219641A1 (pl)
CZ (1) CZ20041054A3 (pl)
DE (1) DE60321672D1 (pl)
EA (1) EA006846B1 (pl)
GE (1) GEP20063991B (pl)
HU (1) HUP0500438A3 (pl)
NO (1) NO20044502L (pl)
PL (1) PL372698A1 (pl)
SK (1) SK286107B6 (pl)
UA (1) UA74991C2 (pl)
WO (1) WO2003086365A1 (pl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750145T2 (de) * 1986-06-10 1994-11-03 Euro Celtique Sa Zusammensetzung mit kontrollierter Freisetzung von Dihydrocodein.
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
DE19747261A1 (de) * 1997-10-25 1999-04-29 Bayer Ag Osmotisches Arzneimittelfreisetzungssystem
KR100889069B1 (ko) * 1999-10-29 2009-03-17 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
SK285128B6 (sk) * 1999-12-28 2006-07-07 Zentiva, A. S. Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy

Also Published As

Publication number Publication date
ATE398446T1 (de) 2008-07-15
SK286107B6 (sk) 2008-03-05
EA200401357A1 (ru) 2005-04-28
NO20044502L (no) 2004-10-26
EP1494656A1 (en) 2005-01-12
SK5012002A3 (en) 2003-11-04
AU2003219641A1 (en) 2003-10-27
CZ20041054A3 (cs) 2005-01-12
PL372698A1 (pl) 2005-07-25
HUP0500438A2 (hu) 2005-08-29
HUP0500438A3 (en) 2008-03-28
WO2003086365A1 (en) 2003-10-23
EP1494656B1 (en) 2008-06-18
DE60321672D1 (de) 2008-07-31
GEP20063991B (en) 2006-12-11
EA006846B1 (ru) 2006-04-28

Similar Documents

Publication Publication Date Title
CN100402585C (zh) 多孔纤维素聚集体以及包含这种聚集体的组合物成形品
TW200529803A (en) Extrusion process for forming chemically stable drug multiparticulates
CN101480384A (zh) 包含非诺贝酸、其生理可接受的盐或衍生物的制剂
RU2208436C2 (ru) Способ изготовления фармацевтических лекарственных форм и их предшественников и фармацевтическая лекарственная форма
EP4056638A1 (en) Cellulose composition, tablet, and orally disintegrating tablet
CN112603900A (zh) 含[(4-羟基-1-甲基-7-苯氧基-异喹啉-3-羰基)-氨基]-乙酸的固体制剂
CZ303694B6 (cs) Prípravek nesteroidního protizánetlivého léciva obsahující granulární a extragranulární kompozici a zpusob jeho prípravy
CA2397942C (en) Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation
JP5663238B2 (ja) 内服固形製剤及びその製造方法
RU2414888C1 (ru) Таблетка из активной фармацевтической субстанции (варианты) и способ ее получения
JP2011246428A (ja) 口腔内崩壊型医薬品及びその製造方法
UA74991C2 (en) Oral therapeutic composition with controlled release of dihydrocodeine
CN114983954A (zh) 叶酸片及其制备方法
EP3256105B1 (en) Method of producing a granulated composition
JP2022076474A (ja) リバーロキサバン含有口腔内崩壊錠
JP2005255619A (ja) 昇華性活性成分および多孔質セルロース粒子含有固形製剤組成物
JP5817715B2 (ja) 固形医薬組成物、医薬製剤及び固形医薬組成物の製造方法
EP4692178A1 (en) Cellulose powder and molded body
HK40061866B (zh) 一种抗心律失常的药物组合物及制备方法
CN118340731A (zh) 一种硫酸瑞美吉泮药物组合物及其制备方法
CN121941725A (zh) 纤维素粉末及成形体
TR2022018634A2 (tr) Geli̇şti̇ri̇lmi̇ş prasugrel hi̇droklorür fi̇lm kapli tablet formülasyonlari i̇çi̇n üreti̇m yöntemi̇
CZ20131028A3 (cs) Kombinovaný perorální přípravek s řízeným uvolňováním kyseliny acetylsalicylové a způsob přípravy
SK6002Y1 (sk) Combined peroral controlled-release formulation of acetylsalicylic acid
HU191102B (en) Process for producing pharmaceutical compositions of regulated dissolution of the active agents containing water-soluble inorganic pharmacons